Since its approval by the U.S. Food and Drug Administration in 2006, Januvia has become one of the most popular drugs to help treat type 2 diabetes. Each year, the medication brings in billions of dollars for manufacturer Merck & Co.
While Januvia has helped countless people control their blood sugar levels by stimulating the pancreas to release more insulin, a growing number of people have reported unexpected side effects like pancreatitis, pancreatic cancer, and thyroid cancer.
Hundreds of victims of Januvia side effects have filed lawsuits in courts around the country. Nearly a thousand people have cases pending in multidistrict litigation against Merck & Co. over claims that the company — along with other makers of similar type 2 diabetes drugs — concealed the risks from the public and made defective drugs.
Learn more about how Januvia works and the status of Januvia lawsuits.